TRV 102.37 The Travelers Companies Inc $TRV Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2014 at 5:09 AM

TRV 102.37 The Travelers Companies Inc $TRV Hit a 52 week high of 102.47 Currently at 102.37 +0.46 +0.45% With a day low of 101.70 and a total volume of 1,434,500.

TRV The Travelers Companies Inc Recent Headline News

ProAssurance Q3 Earnings Miss Estimates, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:30AM CST
ProAssurance Corporation (PRA) reported third-quarter 2014 operating earnings per share of 68 cents, which lagged the Zacks Consensus Estimate of 73 cents.
ACE: 110.81 (+0.08), RLI: 49.31 (unch), PRA: 45.23 (+0.76), TRV: 102.37 (+0.46)

United Fire Posts In-Line Q3 Loss, Faces High Expense Drag - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 10:00AM CST
United Fire (UFCS) reported third-quarter 2014 operating loss of one cent per share, in line with the Zacks Consensus Estimate.
UFCS: 30.26 (-0.09), ACE: 110.81 (+0.08), RLI: 49.31 (unch), TRV: 102.37 (+0.46)

RenaissanceRe Misses on Q3 Earnings as Revenues Decline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:30AM CST
RenaissanceRe's (RNR) third-quarter 2014 operating earnings per share of $2.49 missed the Zacks Consensus Estimate and declined year-over- year as revenues declined and expenses increased.
ACE: 110.81 (+0.08), RLI: 49.31 (unch), RNR: 101.58 (+0.27), TRV: 102.37 (+0.46)

SmarTrend Watching for Potential Pullback in Shares of Travelers After 1.18% Gain
Comtex SmarTrend(R) - Tue Nov 04, 4:34PM CST
Travelers (NYSE:TRV) traded in a range yesterday that spanned from a low of $99.82 to a high of $101.43. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $101.19 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TRV: 102.37 (+0.46)

Travelers Rises 1.18% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Nov 04, 4:33PM CST
Travelers (NYSE:TRV) traded in a range yesterday that spanned from a low of $99.82 to a high of $101.43. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $101.19 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TRV: 102.37 (+0.46)

AmTrust Financial Beats on Q3 Earnings as Revenues Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:30PM CST
AmTrust Financial (AFSI) posted operating net earnings of $1.70 per share, surpassing the Zacks Consensus Estimate by 46% and being more than double the year-ago number on higher revenues.
ACE: 110.81 (+0.08), RLI: 49.31 (unch), AFSI: 49.89 (-0.58), TRV: 102.37 (+0.46)

3 Financial Stocks Pushing Sector Growth
at The Street - Tue Nov 04, 1:13PM CST
TheStreet highlights 3 stocks pushing the financial sector higher today.
ACE: 110.81 (+0.08), TRV: 102.37 (+0.46), MMC: 55.80 (-0.07)

Stocks Narrow Losses; Airlines Lead
at Investor's Business Daily - Tue Nov 04, 12:29PM CST
Stocks narrowed losses near midday Tuesday, but some leaders remained under pressure. The Nasdaq fell 0.6%, the S&P 500 dropped 0.4%, and the Dow Jones industrial average was down a fraction. Wal-Mart Stores (WMT), Travelers (TRV) and Procter &...
LCI: 50.17 (-0.82), SAVE: 77.31 (-0.49), WMT: 78.77 (+0.96), PG: 89.13 (+0.23), ATHM: 43.63 (-1.60), TXRH: 31.79 (-0.19), LUV: 38.24 (+0.30), TRV: 102.37 (+0.46)

Dow Jones (DJIA) Today: Travelers Companies (TRV) Higher
at The Street - Tue Nov 04, 12:00PM CST
The Dow component leading the way higher looks to be Travelers Companies (NYSE:TRV), which is sporting a $1.34 gain (+1.3%) bringing the stock to $101.28.
TRV: 102.37 (+0.46)

Dow Jones (DJIA) Today: Travelers Companies (TRV) Lower
at The Street - Mon Nov 03, 1:00PM CST
Holding back the Dow today is Travelers Companies (NYSE:TRV), which is lagging the broader Dow index with a 20-cent decline (-0.2%) bringing the stock to $100.60.
TRV: 102.37 (+0.46)

How Did These 20 Historically Strong October Stocks Hold Up?
at The Street - Mon Nov 03, 9:58AM CST
Historically, October is not the best month for stocks. This month's market volatility put the top 20 stocks in October to the test. Click through to see how they fared.
STT: 77.81 (-0.04), NUE: 54.18 (+0.70), DAL: 42.69 (-0.21), ICE: 218.54 (-1.38), MHFI: 89.94 (-0.05), ORCL: 39.94 (+0.13), ADBE: 71.60 (-0.50), MS: 35.66 (+0.35), ACE: 110.81 (+0.08), BTU: 11.64 (+0.80), GS: 190.71 (-0.29), R: 91.46 (+0.05), EXPD: 44.24 (+0.22), GOOGL: 551.82 (+0.13), SWN: 36.50 (+0.95), NDAQ: 43.88 (-0.02), AAPL: 109.01 (+0.31), MA: 84.80 (-0.95), TRV: 102.37 (+0.46)

Today's Water-Logged And Getting Wetter Stock: Travelers Companies (TRV)
at The Street - Thu Oct 30, 12:50PM CDT
Trade-Ideas LLC identified Travelers Companies (TRV) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
TRV: 102.37 (+0.46)

AXIS Capital Q3 Earnings Beat Estimates, Top Line Improves - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 12:50PM CDT
AXIS Capital's (AXS) third-quarter 2014 earnings per share of $1.27 outperformed the Zacks Consensus Estimate by about 7% but slumped 27% year over year.
AXS: 49.46 (+0.29), ACE: 110.81 (+0.08), RLI: 49.31 (unch), TRV: 102.37 (+0.46)

CNO Financial's Q3 Earnings Beat Estimates, Improve Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 10:50AM CDT
CNO Financial Group Inc. (CNO) reported third-quarter 2014 operating earnings of 35 cents per share that was higher than the Zacks Consensus Estimate by 9.4%.
ACE: 110.81 (+0.08), RLI: 49.31 (unch), CNO: 18.12 (-0.08), TRV: 102.37 (+0.46)

Virginia Association of Community Banks Selects Travelers as Endorsed Provider for State's Community Banks
Business Wire - Tue Oct 28, 11:04AM CDT
Travelers (NYSE: TRV) has been selected by the Virginia Association of Community Banks (VACB) as an endorsed provider of bank insurance products. Member banks now have access through the Association to the Travelers property and casualty products, as well as SelectOne+(R) for Community Banks, which includes a broad set of coverages on specialty lines.
TRV: 102.37 (+0.46)

PartnerRe Earnings Top Estimates, Tank Y/Y on High Expense - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 11:00AM CDT
PartnerRe Ltd.'s (PRE) third-quarter 2014 operating earnings beat the Zacks Consensus Estimate but lagged the year-ago quarter results.
PRE: 116.35 (-0.36), AFSI: 49.89 (-0.58), ENH: 58.20 (+0.46), TRV: 102.37 (+0.46)

Montpelier Q3 Earnings Beat, Down Y/Y on Less Underwriting - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 10:50AM CDT
Montpelier's (MRH) operating earnings of 86 cents per share in the third quarter, beat the Zacks Consensus Estimate by a couple of cents but declined 38% year over year.
MRH: 32.81 (-0.01), ACE: 110.81 (+0.08), RLI: 49.31 (unch), TRV: 102.37 (+0.46)

XL Group Q3 Earnings Beat on Steady Growth in Underwriting - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 10:40AM CDT
XL Group's (XL) third-quarter 2014 operating net income of 70 cents per share, which beat the Zacks Consensus Estimate by 9% marked four straight quarters of positive earnings surprise.
ACE: 110.81 (+0.08), RLI: 49.31 (unch), XL: 34.36 (+0.02), TRV: 102.37 (+0.46)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

111, Inc. Strategizes with Advisors Amid Proposal Talks

Every time a company's board starts tossing around phrases like "strategic alternatives," you’ve got to pay closer attention. 111, Inc., holding the NASDAQ ticker YI, is one such entity at a crossroads. They've enlisted Houlihan Lokey China Limited as their independent financial advisor and Kirkland & Ellis as their U.S. legal counsel to sift through potential strategic...

Cognizant & EBRD Unite for Tech Transformation Push

An Unexpected Collaboration to Watch Sometimes partnerships come out of left field, like this one between Cognizant and the European Bank for Reconstruction and Development (EBRD). These two are teaming up to inject some serious tech smarts into the Bank's operations over the next five years. What's interesting here is the role AI and automation play in their grand...

ASICS and University of Michigan Launch Innovation Lab

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Docusign and SAP Team Up for Seamless Business Flow

Docusign Brings Its A-Game with SAP Partnership Waking up to find Docusign (NASDAQ:DOCU) teaming up with SAP is like getting a surprise deal at the Saturday market—unexpected but welcome. These two giants in their respective fields are joining forces to plant Docusign’s Intelligent Agreement Management (IAM) directly into SAP Sales Cloud and SAP SuccessFactors. If...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Tennessee's Bold Lung Cancer Trial Signals Innovation

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Air Sealing First: Boosting Home Comfort & Efficiency

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Sintilimab Poised for New Milestone in Melanoma Fight

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Reimagining Water: A Crisis and a Call to Action

Time for a Change The head of the World Water Council, Loïc Fauchon, didn't mince words at the 9th Cairo Water Week. He proclaimed the old methods of water management are sinking under a flood of modern challenges. Toss in climate upheavals, ballooning cities, and unpredictable diets, and you've got yourself a swirling mess that traditional strategies just can’t mop...